Albert David Limited
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
Albert David Limited (ALBERTDAVD) - Net Assets
Latest net assets as of September 2025: ₹3.94 Billion INR
Based on the latest financial reports, Albert David Limited (ALBERTDAVD) has net assets worth ₹3.94 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹5.33 Billion) and total liabilities (₹1.39 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹3.94 Billion |
| % of Total Assets | 73.91% |
| Annual Growth Rate | 13.41% |
| 5-Year Change | 60.6% |
| 10-Year Change | 186.84% |
| Growth Volatility | 10.65 |
Albert David Limited - Net Assets Trend (2006–2025)
This chart illustrates how Albert David Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Albert David Limited (2006–2025)
The table below shows the annual net assets of Albert David Limited from 2006 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹3.92 Billion | +2.48% |
| 2024-03-31 | ₹3.83 Billion | +22.92% |
| 2023-03-31 | ₹3.12 Billion | +11.48% |
| 2022-03-31 | ₹2.79 Billion | +14.36% |
| 2021-03-31 | ₹2.44 Billion | +9.69% |
| 2020-03-31 | ₹2.23 Billion | +5.87% |
| 2019-03-31 | ₹2.10 Billion | +13.18% |
| 2018-03-31 | ₹1.86 Billion | +24.91% |
| 2017-03-31 | ₹1.49 Billion | +8.80% |
| 2016-03-31 | ₹1.37 Billion | +47.41% |
| 2015-03-31 | ₹928.22 Million | +2.75% |
| 2014-03-31 | ₹903.42 Million | +11.39% |
| 2013-03-31 | ₹811.07 Million | +7.35% |
| 2012-03-31 | ₹755.53 Million | +6.55% |
| 2011-03-31 | ₹709.10 Million | +12.47% |
| 2010-03-31 | ₹630.49 Million | +13.05% |
| 2009-03-31 | ₹557.69 Million | +10.26% |
| 2008-03-31 | ₹505.80 Million | +7.36% |
| 2007-03-31 | ₹471.12 Million | +31.16% |
| 2006-03-31 | ₹359.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Albert David Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 249093100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹2.49 Billion | 63.47% |
| Common Stock | ₹57.07 Million | 1.45% |
| Other Comprehensive Income | ₹1.35 Billion | 34.28% |
| Other Components | ₹31.47 Million | 0.80% |
| Total Equity | ₹3.92 Billion | 100.00% |
Albert David Limited Competitors by Market Cap
The table below lists competitors of Albert David Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Far East Gold Ltd
AU:FEG
|
$15.85 Million |
|
KRY
F:KRY
|
$15.85 Million |
|
Libero Copper & Gold Corporation
OTCQB:LBCMF
|
$15.86 Million |
|
Lithium Universe Limited
PINK:LUVSF
|
$15.88 Million |
|
Lifestyle Global Enterprise
TWO:8066
|
$15.84 Million |
|
Mahindra EPC Irrigation Limited
NSE:MAHEPC
|
$15.84 Million |
|
Bflysoft Co. Ltd.
KQ:148780
|
$15.84 Million |
|
Advicenne
PA:ALDVI
|
$15.84 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Albert David Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,829,810,000 to 3,924,834,000, a change of 95,024,000 (2.5%).
- Net income of 172,008,000 contributed positively to equity growth.
- Dividend payments of 65,481,000 reduced retained earnings.
- Other comprehensive income decreased equity by 8,222,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹172.01 Million | +4.38% |
| Dividends Paid | ₹65.48 Million | -1.67% |
| Other Comprehensive Income | ₹-8.22 Million | -0.21% |
| Other Changes | ₹-3.28 Million | -0.08% |
| Total Change | ₹- | 2.48% |
Book Value vs Market Value Analysis
This analysis compares Albert David Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.97x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 10.64x to 0.97x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-03-31 | ₹62.94 | ₹669.90 | x |
| 2007-03-31 | ₹82.55 | ₹669.90 | x |
| 2008-03-31 | ₹88.63 | ₹669.90 | x |
| 2009-03-31 | ₹97.72 | ₹669.90 | x |
| 2010-03-31 | ₹110.47 | ₹669.90 | x |
| 2011-03-31 | ₹124.25 | ₹669.90 | x |
| 2012-03-31 | ₹132.38 | ₹669.90 | x |
| 2013-03-31 | ₹142.11 | ₹669.90 | x |
| 2014-03-31 | ₹158.30 | ₹669.90 | x |
| 2015-03-31 | ₹162.64 | ₹669.90 | x |
| 2016-03-31 | ₹239.75 | ₹669.90 | x |
| 2017-03-31 | ₹260.84 | ₹669.90 | x |
| 2018-03-31 | ₹325.81 | ₹669.90 | x |
| 2019-03-31 | ₹368.74 | ₹669.90 | x |
| 2020-03-31 | ₹390.38 | ₹669.90 | x |
| 2021-03-31 | ₹428.20 | ₹669.90 | x |
| 2022-03-31 | ₹489.68 | ₹669.90 | x |
| 2023-03-31 | ₹545.92 | ₹669.90 | x |
| 2024-03-31 | ₹671.05 | ₹669.90 | x |
| 2025-03-31 | ₹687.72 | ₹669.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Albert David Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.38%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.97%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 1.30x
- Recent ROE (4.38%) is below the historical average (14.23%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 20.65% | 6.40% | 1.27x | 2.54x | ₹38.25 Million |
| 2007 | 28.01% | 9.45% | 0.97x | 3.06x | ₹84.83 Million |
| 2008 | 14.51% | 4.64% | 1.06x | 2.96x | ₹22.82 Million |
| 2009 | 13.50% | 4.09% | 1.14x | 2.89x | ₹19.49 Million |
| 2010 | 16.30% | 5.06% | 1.10x | 2.93x | ₹39.69 Million |
| 2011 | 15.30% | 4.96% | 1.31x | 2.35x | ₹37.55 Million |
| 2012 | 10.10% | 3.30% | 1.14x | 2.68x | ₹730.70K |
| 2013 | 10.55% | 3.26% | 1.25x | 2.58x | ₹4.48 Million |
| 2014 | 13.92% | 4.34% | 1.46x | 2.19x | ₹35.39 Million |
| 2015 | 14.76% | 4.27% | 1.66x | 2.08x | ₹44.18 Million |
| 2016 | 35.08% | 14.96% | 1.43x | 1.64x | ₹343.13 Million |
| 2017 | 8.08% | 3.97% | 1.23x | 1.66x | ₹-28.51 Million |
| 2018 | 5.29% | 3.42% | 0.99x | 1.56x | ₹-87.54 Million |
| 2019 | 12.66% | 8.52% | 1.06x | 1.40x | ₹55.95 Million |
| 2020 | 8.60% | 6.02% | 0.99x | 1.44x | ₹-31.11 Million |
| 2021 | 9.06% | 8.99% | 0.72x | 1.40x | ₹-22.95 Million |
| 2022 | 12.62% | 11.29% | 0.78x | 1.44x | ₹73.11 Million |
| 2023 | 11.61% | 10.59% | 0.81x | 1.36x | ₹50.18 Million |
| 2024 | 19.69% | 20.93% | 0.72x | 1.30x | ₹371.22 Million |
| 2025 | 4.38% | 4.97% | 0.68x | 1.30x | ₹-220.48 Million |
Industry Comparison
This section compares Albert David Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $13,556,428,803
- Average return on equity (ROE) among peers: 15.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Albert David Limited (ALBERTDAVD) | ₹3.94 Billion | 20.65% | 0.35x | $15.85 Million |
| Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) | $802.45 Million | 7.70% | 1.12x | $11.20 Million |
| Aarti Drugs Limited (AARTIDRUGS) | $1.12 Billion | 12.32% | 2.74x | $149.72 Million |
| Abbott India Limited (ABBOTINDIA) | $42.33 Billion | 33.41% | 0.40x | $1.59 Billion |
| Ajanta Pharma Limited (AJANTPHARM) | $15.68 Billion | 32.33% | 0.16x | $1.46 Billion |
| Akums Drugs and Pharmaceutical (AKUMS) | $7.20 Billion | -0.56% | 3.88x | $123.83 Million |
| Alivus Life Sciences Limited (ALIVUS) | $28.17 Billion | 17.24% | 0.21x | $333.13 Million |
| Alkem Laboratories Limited (ALKEM) | $23.74 Billion | 20.90% | 0.71x | $2.41 Billion |
| Alpa Laboratories Limited (ALPA) | $56.73 Million | 0.53% | 2.47x | $5.55 Million |
| Amrutanjan Health Care Limited (AMRUTANJAN) | $2.91 Billion | 13.70% | 0.25x | $77.60 Million |